Ignite Creation Date:
2025-12-24 @ 5:42 PM
Ignite Modification Date:
2026-01-04 @ 5:27 AM
Study NCT ID:
NCT02744768
Status:
UNKNOWN
Last Update Posted:
2018-03-22
First Post:
2016-04-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
D-ALBA Frontline Sequential Dasatinib and Blinatumomab in Adult Philadelphia Positive Acute Lymphoblastic Leukemia
Sponsor:
Gruppo Italiano Malattie EMatologiche dell'Adulto
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-05-31
Start Date Type:
ACTUAL
Primary Completion Date:
2021-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-06
Completion Date Type:
ESTIMATED
First Submit Date:
2016-04-11
First Submit QC Date:
None
Study First Post Date:
2016-04-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-03-21
Last Update Post Date:
2018-03-22
Last Update Post Date Type:
ACTUAL